1-20 of 23
Luciano Masini
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Bendamustine, Low-Dose Dexamethasone, and Lenalidomide (BdL) For The Treatment Of Patients With Relapsed Multiple Myeloma Confirms Very Promising Results In a Phase I/II Study

Samantha Pozzi, MD, Stefania Badiali, MS, Alessandro Corso, MD, Pellegrino Musto, MD, Attilio Guarini, MD, Carla Minoia, MD, Donatella Vincelli, MD, Roberto Ria, MD, Luciano Masini, MD, Giovanni Quarta, MD, Massimo Gentile, MD, Carla Mazzone, MD, Antonio Palumbo, MD, Fortunato Morabito, MD, Stefano Sacchi, MD
Journal: Blood
Blood (2013) 122 (21): 3212.
https://doi.org/10.1182/blood.V122.21.3212.3212
Published: 2013
Journal Articles

A Phase I/II Study of Bendamustine, Low-Dose Dexamethasone, and Lenalidomide (BdL) for the Treatment of Patients with Relapsed Multiple Myeloma

Stefano Sacchi, Samantha Pozzi, Stefania Badiali, Attilio Guarini, Carla Mazzone, Alessandro Corso, Donatella Vincelli, Luciano Masini, Pellegrino Musto, Roberto Ria, Giovanni Quarta, Antonio Lazzaro, Antonio Palumbo, Fortunato Morabito
Journal: Blood
Blood (2012) 120 (21): 1851.
https://doi.org/10.1182/blood.V120.21.1851.1851
Published: 2012
Journal Articles

Bortezomib-Thalidomide-Dexamethasone Incorporated Into Autotransplantation Is Associated with More Favorable Outcomes After Relapse in Comparison with Thalidomide-Dexamethasone Plus Autotransplantation in Multiple Myeloma

Michele Cavo, MD, Monica Galli, MD, Lucia Pantani, MD, Francesco Di Raimondo, MD, Claudia Crippa, MD, Massimo Offidani, MD, Elena Zamagni, MD, Vittorio Montefusco, MD, Franco Narni, MD, Annalisa Pezzi, Antonio Spadano, MD, Norbert Pescosta, MD, Paola Tacchetti, MD, Luca Baldini, MD, Antonio Ledda, MD, Claudia Cellini, MD, Tommaso Caravita, MD, Antonietta Falcone, MD, Chiara Nozzoli, MD, Renato Zambello, MD, Luciano Masini, MD, Mario Boccadoro, MD
Journal: Blood
Blood (2012) 120 (21): 4210.
https://doi.org/10.1182/blood.V120.21.4210.4210
Published: 2012
Journal Articles

Ten Year-Long Term Survival After up-Front Autologous Stem Cell Transplantation in Multiple Myeloma: Results From Two Prospective Clinical Trials

Elena Zamagni, MD, Francesco Di Raimondo, MD, Francesca Patriarca, Patrizia Tosi, Annalisa Pezzi, Claudia Cellini, Paola Tacchetti, MD, Sonia Ronconi, Silvestro Volpe, Lucia Pantani, MD, Lucio Catalano, Mauro Fiacchini, Emanuele Angelucci, Luciano Masini, Alessandro Gozzetti, Piero Galieni, Beatrice Zannetti, Franco Narni, Annamaria Brioli, Carolina Terragna, PhD, Antonio Lazzaro, Katia Mancuso, Catello Califano, Antonio Ledda, Nicoletta Testoni, Michele Baccarani, MD, Michele Cavo, MD
Journal: Blood
Blood (2012) 120 (21): 594.
https://doi.org/10.1182/blood.V120.21.594.594
Published: 2012
Journal Articles

Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma

Clinical Trials & Observations
Michele Cavo, Lucia Pantani, Maria Teresa Petrucci, Francesca Patriarca, Elena Zamagni, Daniela Donnarumma, Claudia Crippa, Mario Boccadoro, Giulia Perrone, Antonietta Falcone, Chiara Nozzoli, Renato Zambello, Luciano Masini, Anna Furlan, Annamaria Brioli, Daniele Derudas, Stelvio Ballanti, Maria Laura Dessanti, Valerio De Stefano, Angelo Michele Carella, Magda Marcatti, Andrea Nozza, Felicetto Ferrara, Vincenzo Callea, Catello Califano, Annalisa Pezzi, Anna Baraldi, Mariella Grasso, Pellegrino Musto, Antonio Palumbo
Journal: Blood
Blood (2012) 120 (1): 9–19.
https://doi.org/10.1182/blood-2012-02-408898
Published: 2012
Includes: Supplemental data
Journal Articles

Post-Approval Safety Study (PASS) of Lenalidomide Compared with Other Treatments in Patients with Relapsed or Refractory Multiple Myeloma

Michele Cavo, MD, Luciano Masini, Igor W. Blau, Miguel T. Hernandez, Renato Zambello, Paolo de Fabritiis, Christian Berthou, Argiris Symeonidis, Jennifer Bird, Javier De La Rubia, Pamela Bacon, Barbara Rosettani, Elisabeth Kueenburg, Neil Minton
Journal: Blood
Blood (2011) 118 (21): 1867.
https://doi.org/10.1182/blood.V118.21.1867.1867
Published: 2011
Journal Articles

Superior Complete Response Rate (CR) and Progression-Free Survival (PFS) with Bortezomib-Thalidomide-Dexamethasone (VTD) Versus Thalidomide-Dexamethasone (TD) As Consolidation Therapy After Autologous Stem-Cell Transplantation (ASCT) in Multiple Myeloma (MM)

Michele Cavo, MD, Lucia Pantani, MD, Francesca Patriarca, MD, Maria Teresa Petrucci, Monica Galli, MD, Francesco Di Raimondo, MD, Giuseppe Rossi, MD, Antonio Palumbo, MD, Paola Tacchetti, MD, Massimo Offidani, MD, Vittorio Montefusco, MD, Franco Narni, MD, Tonino Spadano, MD, Claudia Cellini, MD, Norbert Pescosta, MD, Luca Baldini, MD, Antonio Ledda, MD, Tommaso Caravita Di Toritto, MD, Annalisa Pezzi, Statistician, Antonietta Falcone, MD, Chiara Nozzoli, MD, Renato Zambello, MD, Luciano Masini, MD, Filippo Gherlinzoni, MD, Maria Concetta Petti, MD, Daniele Derudas, MD, Stelvio Ballanti, MD, Valerio De Stefano, MD, Michele Baccarani, MD
Journal: Blood
Blood (2011) 118 (21): 1871.
https://doi.org/10.1182/blood.V118.21.1871.1871
Published: 2011
Journal Articles

Evaluation of Atypical Low Energy Fractures in Patients Affected by Multiple Myeloma Treated with Bispohosphonates

Samantha Pozzi, MD, Raffaella Marcheselli, MS, Alessia Bari, MD, Eliana Valentina Liardo, MD, Paola Bresciani, MD, Maria Teresa Donini, MD, Santo Neri, MD, Luciano Masini, Giuseppe Caparrotti, MD, Pellegrino Musto, Elisa Ferraris, MD, Daniela Petro, MD, Luigi Marcheselli, MS, Antonio Palumbo, MD, Stefano Sacchi, MD
Journal: Blood
Blood (2011) 118 (21): 5134.
https://doi.org/10.1182/blood.V118.21.5134.5134
Published: 2011
Journal Articles

Analysis of Toxicity and Efficacy of Subcutaneous Cladribine at Reduced or Standard Doses (Five Versus Seven Consecutive Days) In Patients with Hairy Cell Leukemia (HCL) In the ICGHCL2004 Protocol by the Italian Cooperative Group on Hcl

Francesco Forconi, MD, Emanuele Cencini, Francesco Zaja, Tamara Intermesoli, Francesca Fiore, Benedetta Puccini, Caterina Stelitano, Renato Cantaffa, Alessandro Pulsoni, Alfonso Zaccaria, Pier Luigi Zinzani, MD, PhD, Andrea Piccin, MD, Filippo Gherlinzoni, MD, Alessandro Levis, MD, Giovanni Martinelli, MD, Sara Barulli, Fortunato Morabito, MD, Ivana Pierri, Miriana Ruggeri, Alessandra Caremani, Luciano Masini, Giuseppe Polimeno, Angelo Guerrasio, Elisa Sozzi, Davide Rossi, Piero Galieni, Marco Gobbi, MD, Sergio Cortelazzo, Luigi Rigacci, MD, Andrea Gallamini, MD, Robin Foà, MD, Francesco Lauria, MD
Journal: Blood
Blood (2010) 116 (21): 701.
https://doi.org/10.1182/blood.V116.21.701.701
Published: 2010
Journal Articles

Molecular Remission After Bortezomib-Thalidomide-Dexamethasone Compared with Thalidomide-Dexamethasone as Consolidation Therapy Following Double Autologous Transplantation for Multiple Myeloma: Results of a Qualitative and Quantitative Analysis

Carolina Terragna, Elena Zamagni, Maria Teresa Petrucci, Sandra Durante, Francesca Patriarca, Franco Narni, Claudia Crippa, Ausilia Gorgone, Tommaso Caravita, Giulia Perrone, Chiara Nozzoli, Luciano Masini, Vincenzo Callea, Immacolata Attolico, Claudia Cellini, Sara Bringhen, Antonio Ledda, Vittorio Montefusco, Marina Martello, Giovanni Martinelli, Michele Baccarani, Michele Cavo
Journal: Blood
Blood (2010) 116 (21): 861.
https://doi.org/10.1182/blood.V116.21.861.861
Published: 2010
Journal Articles

Analysis of Parameters Predicting Treatment Efficacy and Outcome In Patients with Hairy Cell Leukemia (HCL) Receiving Subcutaneous Cladribine In the ICGHCL2004 Protocol (by the Italian Cooperative Group on HCL)

Francesco Forconi, MD, Emanuele Cencini, Francesco Zaja, Tamara Intermesoli, Francesca Fiore, Benedetta Puccini, Caterina Stelitano, Renato Cantaffa, Alessandro Pulsoni, Alfonso Zaccaria, Pier Luigi Zinzani, MD, PhD, Andrea Piccin, MD, Filippo Gherlinzoni, MD, Alessandro Levis, MD, Giovanni Martinelli, MD, Sara Barulli, Fortunato Morabito, MD, Ivana Pierri, Miriana Ruggeri, Alessandra Caremani, Luciano Masini, Giuseppe Polimeno, Angelo Guerrasio, Elisa Sozzi, Davide Rossi, Francesco Bertoni, Piero Galieni, Marco Gobbi, MD, Sergio Cortelazzo, Luigi Rigacci, MD, Andrea Gallamini, MD, Robin Foà, MD, Francesco Lauria, MD
Journal: Blood
Blood (2010) 116 (21): 1369.
https://doi.org/10.1182/blood.V116.21.1369.1369
Published: 2010
Journal Articles

Prognostic Impact of Cytogenetic Abnormalities On Outcomes of Newly Diagnosed Multiple Myeloma Patients Treated with Thalidomide-Dexamethasone Incorporated Into Double Autologous Stem-Cell Transplantation: An Analysis of 593 Patients

Elena Zamagni, Nicoletta Testoni, Carolina Terragna, Paola Tacchetti, Mauro Fiacchini, Francesca Patriarca, Patrizia Tosi, Francesco Di Raimondo, Giulia Marzocchi, Maria Teresa Petrucci, Lucio Catalano, Sandra Durante, Silvestro Volpe, Monica Galli, Luciano Masini, Antonio Ledda, Annamaria Brioli, Claudia Crippa, Alessandro Gozzetti, Franco Narni, Catello Califano, Claudia Cellini, Sara Bringhen, Giuliana Leopardi, Lucia Pantani, Michela Ceccolini, Massimo Offidani, Giulia Perrone, Beatrice Anna Zannetti, Michele Baccarani, MD, Michele Cavo
Journal: Blood
Blood (2010) 116 (21): 3562.
https://doi.org/10.1182/blood.V116.21.3562.3562
Published: 2010
Journal Articles

Bortezomib-Thalidomide-Dexamethasone Compared with Thalidomide-Dexamethasone as Induction and Consolidation Therapy Before and After Double Autologous Transplantation In Newly Diagnosed Multiple Myeloma: Results From a Randomized Phase 3 Study

Michele Cavo, Giulia Perrone, Silvia Buttignol, Elisabetta Calabrese, Monica Galli, Sara Bringhen, Tonino Spadano, Luca Baldini, Tommaso Caravita, Chiara Nozzoli, Annamaria Brioli, Luciano Masini, Anna Furlan, Lucia Pantani, Daniele Derudas, Stelvio Ballanti, Francesco Pisani, Valerio De Stefano, Gioacchino Catania, Luca Castagna, Felicetto Ferrara, Vincenzo Callea, Pellegrino Musto, Elena Zamagni, Michele Baccarani
Journal: Blood
Blood (2010) 116 (21): 42.
https://doi.org/10.1182/blood.V116.21.42.42
Published: 2010
Journal Articles

A Phase III Study of Enoxaparin Vs Aspirin as Thromboprophylaxis for Newly Diagnosed Myeloma Patients Treated with Lenalidomide-Based Regimen.

Federica Cavallo, Francesco Di Raimondo, Izhar Harda, Barbara Lupo, Alessandra Romano, Lucio Catalano, Luca Baldini, Tommasina Guglielmelli, Luciano Masini, Davide Rossi, Roberto Ria, Giulia Benevolo, Antonietta Pia Falcone, Norbert Pescosta, Monica Galli, Anna Baraldi, Valter Redoglia, Mario Boccadoro, Antonio Palumbo
Journal: Blood
Blood (2010) 116 (21): 1092.
https://doi.org/10.1182/blood.V116.21.1092.1092
Published: 2010
Journal Articles

Post-Approval Safety Study (PASS) of Lenalidomide Compared with Other Treatments In Patients with Relapsed or Refractory Multiple Myeloma: Evaluation of Peripheral Neuropathy In the First 1,011 Patients

Michel Delforge, Igor W. Blau, Miguel T. Hernandez, Roman Hajek, Luciano Masini, Henk Lokhorst, Giacinto La Verde, Laurence Sanhes, Javier De La Rubia, Janine Collins, Barbara Rosettani, Nancy A Brandenburg, Renato Zambello
Journal: Blood
Blood (2010) 116 (21): 1939.
https://doi.org/10.1182/blood.V116.21.1939.1939
Published: 2010
Journal Articles

A Phase III Study of Double Autotransplantation Incorporating Bortezomib-Thalidomide-Dexamethasone (VTD) or Thalidomide-Dexamethasone (TD) for Multiple Myeloma: Superior Clinical Outcomes with VTD Compared to TD.

Michele Cavo, M.D., Paola Tacchetti, M.D., Francesca Patriarca, M.D., Maria Teresa Petrucci, M.D., Lucia Pantani, M.D., Monica Galli, M.D., Francesco Di Raimondo, M.D., Claudia Crippa, M.D., Sara Bringhen, M.D., Massimo Offidani, M.D., Franco Narni, M.D., Vittorio Montefusco, M.D., Elena Zamagni, M.D., Tonino Spadano, M.D., Norbert Pescosta, M.D., Luca Baldini, M.D., Claudia Cellini, M.D., Tommaso Caravita, M.D., Antonio Ledda, M.D., Antonietta Falcone, M.D., Patrizia Tosi, M.D., Chiara Nozzoli, M.D., Renato Zambello, M.D., Luciano Masini, M.D., Paola Agostini, M.D., Mauro Fiacchini, M.D., Michele Baccarani, M.D.
Journal: Blood
Blood (2009) 114 (22): 351.
https://doi.org/10.1182/blood.V114.22.351.351
Published: 2009
Journal Articles

Incorporation of Thalidomide-Dexamethasone (Thal-Dex) into up-Front Double Autologous Stem-Cell Transplantation (ASCT) for multiple Myeloma: Final analysis of phase II “Bologna 2002” Study.

Elena Zamagni, M.D., Nicoletta Testoni, B.S., Carolina Terragna, B.S., Paola Tacchetti, M.D., Chiara Nicci, B.S., Patrizia Tosi, M.D., Mauro Fiacchini, M.D., Francesca Patriarca, M.D., Francesco Di Raimondo, M.D., Lucio Catalano, M.D., Francesco Casulli, M.D., Silvestro Volpe, M.D., Luciano Masini, M.D., Antonio Ledda, M.D., Annamaria Brioli, M.D., Delia Cangini, M.D., Alessandro Gozzetti, M.D., Catello Califano, M.D., Claudia Cellini, M.D., Affra Carubelli, M.D., Alessandro Petrucci, M.D., Giuliana Leopardi, M.D., Lucia Pantani, M.D., Michela Ceccolini, M.D., Massimo Offidani, M.D., Giulia Perrone, M.D., Michele Baccarani, M.D., Michele Cavo, M.D.
Journal: Blood
Blood (2009) 114 (22): 349.
https://doi.org/10.1182/blood.V114.22.349.349
Published: 2009
Journal Articles

Superior Rate of Complete Response with up-Front Velcade-Thalidomide-Dexamethasone Versus Thalidomide-Dexamethasone in Newly Diagnosed Multiple Myeloma Is Not Affected by Adverse Prognostic Factors, Including High-Risk Cytogenetic Abnormalities.

Michele Cavo, M.D., Nicoletta Testoni, B.S., Carolina Terragna, B.S., Giulia Marzocchi, B.S., Sandra Durante, B.S., Renato Zambello, M.D., Chiara Nozzoli, M.D., Lucia Pantani, M.D., Paola Tacchetti, M.D., Luciano Masini, M.D., Michela Ceccolini, M.D., Paola Agostini, M.D., Elena Zamagni, M.D., Valerio De Stefano, M.D., Patrizia Tosi, M.D., Daniele Derudas, M.D., Laura Dessanti, M.D., Stelvio Ballanti, M.D., Salvatore Palmieri, M.D., Andrea Nozza, M.D., Gioacchino Catania, M.D., Jacopo Peccatori, M.D., Alfonso D’Arco, M.D., Pellegrino Musto, M.D., Mariella Grasso, M.D., Maria Caterina Pallotti, M.D., Silvana Pasini, M.D., Pier Paolo Fattori, M.D., Anna Baraldi, M.D., Delia Cangini, M.D., Filippo Ballerini, M.D., Alessandro Petrucci, M.D., Michele Baccarani, M.D.
Journal: Blood
Blood (2008) 112 (11): 1662.
https://doi.org/10.1182/blood.V112.11.1662.1662
Published: 2008
Journal Articles

Defibrotide Low-Dose Continuous Infusion from Day +1 Until Day +21 after Allogeneic Stem Cell Transplantation as Prophylaxis of Veno-Occlusive Disease (VOD) of the Liver. A Single Centre Experience.

Alessandro Bonini, Paolo Avanzini, Luciano Masini, Francesco Merli, Fiorella Ilariucci, Barbara Gamberi, Alessia Tieghi, Isabel Alvarez, Annalisa Immovilli, Annalisa Pilia, Luigi Gugliotta
Journal: Blood
Blood (2007) 110 (11): 4927.
https://doi.org/10.1182/blood.V110.11.4927.4927
Published: 2007
Journal Articles

Baseline Thrombophilic Alterations and Risk of Venous Thromboembolism in 266 Multiple Myeloma Patients Primarily Treated with Thalidomide and High-Dose Dexamethasone.

Elena Zamagni, Lelia Valdre, Michela Cini, Cristina Legnani, Patrizia Tosi, Paola Tacchetti, Francesca Patriarca, Michela Ceccolini, Lucio Catalano, Elisa Favaretto, Francesco Casulli, Silvestro Volpe, Giulia Perrone, Luciano Masini, Antonio Ledda, Sadia Falcioni, Annamaria Brioli, Alessandro Gozzetti, Catello Califano, Mariacaterina Pallotti, Claudia Cellini, Affra Carubelli, Lucia Pantani, Michele Baccarani, Gualtiero Palareti, Michele Cavo
Journal: Blood
Blood (2007) 110 (11): 3997.
https://doi.org/10.1182/blood.V110.11.3997.3997
Published: 2007